GEODE CAPITAL MANAGEMENT, LLC - BLUEBIRD BIO INC ownership

BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 178 filers reported holding BLUEBIRD BIO INC in Q1 2023. The put-call ratio across all filers is 0.92 and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of BLUEBIRD BIO INC
ValueSharesWeighting
Q3 2023$6,754,189
-7.5%
2,221,494
+0.1%
0.00%0.0%
Q2 2023$7,303,007
+9.4%
2,219,758
+5.8%
0.00%0.0%
Q1 2023$6,673,684
+58969.6%
2,098,642
+28.5%
0.00%
-50.0%
Q4 2022$11,298
-99.9%
1,632,707
+13.9%
0.00%
+100.0%
Q3 2022$9,074,000
+74.3%
1,433,524
+14.0%
0.00%0.0%
Q2 2022$5,206,000
-4.2%
1,257,612
+12.2%
0.00%0.0%
Q1 2022$5,437,000
-56.0%
1,121,177
-9.4%
0.00%0.0%
Q4 2021$12,363,000
-44.5%
1,237,612
+6.1%
0.00%
-66.7%
Q3 2021$22,290,000
-43.2%
1,166,415
-5.0%
0.00%
-40.0%
Q2 2021$39,266,000
+57.4%
1,227,854
+48.4%
0.01%
+25.0%
Q1 2021$24,941,000
-29.2%
827,244
+1.6%
0.00%
-33.3%
Q4 2020$35,236,000
-14.3%
814,364
+6.9%
0.01%
-25.0%
Q3 2020$41,109,000
-12.2%
761,996
-0.6%
0.01%
-20.0%
Q2 2020$46,816,000
+54.4%
766,975
+16.3%
0.01%
+25.0%
Q1 2020$30,321,000
-72.9%
659,728
-48.2%
0.01%
-33.3%
Q4 2019$111,850,000
+96.9%
1,274,646
+106.0%
0.01%
-7.7%
Q3 2019$56,814,000
-27.5%
618,755
+0.4%
0.01%
-31.6%
Q2 2019$78,385,000
-15.3%
616,235
+4.7%
0.02%
-20.8%
Q1 2019$92,565,000
-15.6%
588,352
-46.8%
0.02%
+41.2%
Q4 2018$109,626,000
+47.4%
1,105,118
+117.0%
0.02%
-19.0%
Q3 2018$74,366,000
-1.5%
509,367
+5.9%
0.02%
-8.7%
Q2 2018$75,497,000
-6.6%
481,029
+1.6%
0.02%
-11.5%
Q1 2018$80,839,000
-0.2%
473,435
+4.1%
0.03%
-7.1%
Q4 2017$81,034,000
+41.3%
454,997
+9.0%
0.03%
+33.3%
Q3 2017$57,331,000
+46.2%
417,409
+11.8%
0.02%
+40.0%
Q2 2017$39,223,000
+21.5%
373,382
+5.1%
0.02%
+15.4%
Q1 2017$32,288,000
+60.2%
355,213
+8.8%
0.01%
+44.4%
Q4 2016$20,151,000
+6.6%
326,610
+17.1%
0.01%
-10.0%
Q3 2016$18,907,000
+62.8%
278,959
+3.9%
0.01%
+66.7%
Q2 2016$11,617,000
+17.6%
268,368
+15.5%
0.01%
+20.0%
Q1 2016$9,876,000
-30.2%
232,398
+5.5%
0.01%
-37.5%
Q4 2015$14,143,000
-22.0%
220,243
+3.9%
0.01%
-27.3%
Q3 2015$18,129,000
-40.5%
211,914
+17.1%
0.01%
-35.3%
Q2 2015$30,472,000
+31.4%
180,987
-5.8%
0.02%
+30.8%
Q1 2015$23,198,000
+113.1%
192,090
+61.9%
0.01%
+116.7%
Q4 2014$10,884,000
+175.8%
118,669
+7.9%
0.01%
+100.0%
Q3 2014$3,947,000
+87.5%
110,007
+101.5%
0.00%
+200.0%
Q2 2014$2,105,000
+101.6%
54,582
+18.8%
0.00%0.0%
Q1 2014$1,044,000
+10.5%
45,930
+1.9%
0.00%0.0%
Q4 2013$945,000
-3.9%
45,063
+23.6%
0.00%0.0%
Q3 2013$983,00036,4450.00%
Other shareholders
BLUEBIRD BIO INC shareholders Q1 2023
NameSharesValueWeighting ↓
Monashee Investment Management LLC 125,000$13,131,0005.55%
Cormorant Asset Management, LP 275,000$28,889,0004.79%
Eventide Asset Management 569,700$59,847,0003.73%
Crosspoint Capital Strategies, LLC 28,937$3,040,0002.66%
Casdin Capital, LLC 65,000$6,828,0002.53%
ARK Investment Management 119,683$12,573,0002.45%
RTW INVESTMENTS, LP 104,383$10,965,0002.31%
Taylor Wealth Management Partners 38,368$4,031,0001.82%
First Light Asset Management, LLC 33,780$3,549,0001.19%
Atika Capital Management LLC 25,000$2,627,0000.92%
View complete list of BLUEBIRD BIO INC shareholders